SK10492003A3 - Spôsob identifikácie, izolácie a produkcie antigénov špecifického patogénu - Google Patents

Info

Publication number

SK10492003A3

SK10492003A3 SK1049-2003A SK10492003A SK10492003A3 SK 10492003 A3 SK10492003 A3 SK 10492003A3 SK 10492003 A SK10492003 A SK 10492003A SK 10492003 A3 SK10492003 A3 SK 10492003A3

Authority

SK

Slovakia

Prior art keywords

seq

amino acids

pct

antigens

reactive

Prior art date

2001-01-26

Links

• Espacenet
• Global Dossier
• Discuss

• 108091007433 antigens Proteins 0.000 title claims abstract description 218
• 102000036639 antigens Human genes 0.000 title claims abstract description 218
• 239000000427 antigen Substances 0.000 title claims abstract description 214
• 244000052769 pathogen Species 0.000 title claims abstract description 94
• 238000000034 method Methods 0.000 title claims abstract description 85
• 230000001717 pathogenic effect Effects 0.000 title claims abstract description 84
• 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
• 238000002955 isolation Methods 0.000 title claims abstract description 5
• 230000000521 hyperimmunizing effect Effects 0.000 claims abstract description 78
• 238000002360 preparation method Methods 0.000 claims abstract description 70
• 241000282414 Homo sapiens Species 0.000 claims abstract description 58
• 229960005486 vaccine Drugs 0.000 claims abstract description 51
• 230000014509 gene expression Effects 0.000 claims abstract description 47
• 238000012216 screening Methods 0.000 claims abstract description 34
• 241001465754 Metazoa Species 0.000 claims abstract description 23
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 18
• 239000013566 allergen Substances 0.000 claims abstract description 14
• 230000005784 autoimmunity Effects 0.000 claims abstract description 12
• 239000000126 substance Substances 0.000 claims abstract description 7
• 150000001413 amino acids Chemical class 0.000 claims description 438
• 210000002966 serum Anatomy 0.000 claims description 148
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 92
• 230000002163 immunogen Effects 0.000 claims description 91
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 68
• 230000000890 antigenic effect Effects 0.000 claims description 63
• 239000012634 fragment Substances 0.000 claims description 58
• 230000001580 bacterial effect Effects 0.000 claims description 39
• 208000015181 infectious disease Diseases 0.000 claims description 34
• 241000191963 Staphylococcus epidermidis Species 0.000 claims description 26
• 241000191967 Staphylococcus aureus Species 0.000 claims description 23
• 150000001875 compounds Chemical class 0.000 claims description 20
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 17
• 230000028993 immune response Effects 0.000 claims description 17
• 230000027455 binding Effects 0.000 claims description 16
• 206010041925 Staphylococcal infections Diseases 0.000 claims description 15
• 239000000203 mixture Substances 0.000 claims description 15
• 108010026552 Proteome Proteins 0.000 claims description 14
• 239000002671 adjuvant Substances 0.000 claims description 14
• 239000003814 drug Substances 0.000 claims description 12
• 210000001519 tissue Anatomy 0.000 claims description 12
• 210000002421 cell wall Anatomy 0.000 claims description 11
• 238000010367 cloning Methods 0.000 claims description 11
• 230000003308 immunostimulating effect Effects 0.000 claims description 11
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 10
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 10
• 239000008194 pharmaceutical composition Substances 0.000 claims description 10
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
• 210000003705 ribosome Anatomy 0.000 claims description 9
• 239000003795 chemical substances by application Substances 0.000 claims description 7
• 238000000746 purification Methods 0.000 claims description 7
• 230000001154 acute effect Effects 0.000 claims description 6
• 239000006166 lysate Substances 0.000 claims description 6
• 210000004408 hybridoma Anatomy 0.000 claims description 5
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
• 210000000952 spleen Anatomy 0.000 claims description 5
• 210000004989 spleen cell Anatomy 0.000 claims description 5
• 241000711549 Hepacivirus C Species 0.000 claims description 4
• 241000725303 Human immunodeficiency virus Species 0.000 claims description 4
• 230000000977 initiatory effect Effects 0.000 claims description 4
• 229920002851 polycationic polymer Polymers 0.000 claims description 4
• 241000589969 Borreliella burgdorferi Species 0.000 claims description 3
• 241000700721 Hepatitis B virus Species 0.000 claims description 3
• 241000709721 Hepatovirus A Species 0.000 claims description 3
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 3
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 3
• 239000000854 Human Growth Hormone Substances 0.000 claims description 3
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 3
• 241000186362 Mycobacterium leprae Species 0.000 claims description 3
• 241000702670 Rotavirus Species 0.000 claims description 3
• 241000714474 Rous sarcoma virus Species 0.000 claims description 3
• 241000193996 Streptococcus pyogenes Species 0.000 claims description 3
• 241000607626 Vibrio cholerae Species 0.000 claims description 3
• 210000001124 body fluid Anatomy 0.000 claims description 3
• 239000010839 body fluid Substances 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 241000712461 unidentified influenza virus Species 0.000 claims description 3
• 241000228257 Aspergillus sp. Species 0.000 claims description 2
• 241000222122 Candida albicans Species 0.000 claims description 2
• 241001647372 Chlamydia pneumoniae Species 0.000 claims description 2
• 241000606153 Chlamydia trachomatis Species 0.000 claims description 2
• 241000194033 Enterococcus Species 0.000 claims description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 2
• 241000193998 Streptococcus pneumoniae Species 0.000 claims description 2
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
• 230000001363 autoimmune Effects 0.000 claims description 2
• 229940095731 candida albicans Drugs 0.000 claims description 2
• 229940038705 chlamydia trachomatis Drugs 0.000 claims description 2
• 238000012258 culturing Methods 0.000 claims description 2
• 230000002538 fungal effect Effects 0.000 claims description 2
• 230000002147 killing effect Effects 0.000 claims description 2
• 239000002244 precipitate Substances 0.000 claims description 2
• 230000002265 prevention Effects 0.000 claims description 2
• 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 2
• 229940118696 vibrio cholerae Drugs 0.000 claims description 2
• 230000003612 virological effect Effects 0.000 claims description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 6
• 241000282326 Felis catus Species 0.000 claims 3
• 229940104302 cytosine Drugs 0.000 claims 3
• 208000034309 Bacterial disease carrier Diseases 0.000 claims 2
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims 2
• CXENHBSYCFFKJS-OXYODPPFSA-N (Z,E)-alpha-farnesene Chemical compound CC(C)=CCC\C(C)=C\C\C=C(\C)C=C CXENHBSYCFFKJS-OXYODPPFSA-N 0.000 claims 1
• BCOSEZGCLGPUSL-UHFFFAOYSA-N 2,3,3-trichloroprop-2-enoyl chloride Chemical compound ClC(Cl)=C(Cl)C(Cl)=O BCOSEZGCLGPUSL-UHFFFAOYSA-N 0.000 claims 1
• JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 claims 1
• VUFNLQXQSDUXKB-DOFZRALJSA-N 2-[4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyloxy]ethyl (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OCCOC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 VUFNLQXQSDUXKB-DOFZRALJSA-N 0.000 claims 1
• 241000220479 Acacia Species 0.000 claims 1
• 241001474033 Acar Species 0.000 claims 1
• VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 claims 1
• 241000726103 Atta Species 0.000 claims 1
• 102100031680 Beta-catenin-interacting protein 1 Human genes 0.000 claims 1
• 102100034330 Chromaffin granule amine transporter Human genes 0.000 claims 1
• 241000252203 Clupea harengus Species 0.000 claims 1
• 101000993469 Homo sapiens Beta-catenin-interacting protein 1 Proteins 0.000 claims 1
• 101000641221 Homo sapiens Chromaffin granule amine transporter Proteins 0.000 claims 1
• 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims 1
• 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 claims 1
• 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 claims 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 claims 1
• 102100035304 Lymphotactin Human genes 0.000 claims 1
• 101100438619 Mus musculus Cpb2 gene Proteins 0.000 claims 1
• 101100226120 Mus musculus Ess2 gene Proteins 0.000 claims 1
• 101100237844 Mus musculus Mmp19 gene Proteins 0.000 claims 1
• 101100107522 Mus musculus Slc1a5 gene Proteins 0.000 claims 1
• 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 claims 1
• 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 claims 1
• 101100029566 Rattus norvegicus Rabggta gene Proteins 0.000 claims 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
• 241000194017 Streptococcus Species 0.000 claims 1
• 201000008754 Tenosynovial giant cell tumor Diseases 0.000 claims 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
• CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims 1
• 125000003118 aryl group Chemical group 0.000 claims 1
• 208000035647 diffuse type tenosynovial giant cell tumor Diseases 0.000 claims 1
• 230000009454 functional inhibition Effects 0.000 claims 1
• 235000019514 herring Nutrition 0.000 claims 1
• 238000000707 layer-by-layer assembly Methods 0.000 claims 1
• 101150075675 tatC gene Proteins 0.000 claims 1
• 208000002918 testicular germ cell tumor Diseases 0.000 claims 1
• 208000037918 transfusion-transmitted disease Diseases 0.000 claims 1
• 238000009941 weaving Methods 0.000 claims 1
• 241000282412 Homo Species 0.000 abstract description 4
• 238000010188 recombinant method Methods 0.000 abstract description 2
• 235000001014 amino acid Nutrition 0.000 description 379
• 229940024606 amino acid Drugs 0.000 description 377
• 108090000623 proteins and genes Proteins 0.000 description 241
• 102000004169 proteins and genes Human genes 0.000 description 226
• 235000018102 proteins Nutrition 0.000 description 224
• 108700026244 Open Reading Frames Proteins 0.000 description 75
• 108020004414 DNA Proteins 0.000 description 62
• 210000004027 cell Anatomy 0.000 description 52
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 46
• 230000009257 reactivity Effects 0.000 description 40
• 238000003384 imaging method Methods 0.000 description 36
• 102000018697 Membrane Proteins Human genes 0.000 description 28
• 108010052285 Membrane Proteins Proteins 0.000 description 28
• 230000006870 function Effects 0.000 description 25
• 210000000805 cytoplasm Anatomy 0.000 description 23
• 239000002609 medium Substances 0.000 description 21
• 235000019687 Lamb Nutrition 0.000 description 20
• 238000004458 analytical method Methods 0.000 description 20
• 241000894006 Bacteria Species 0.000 description 17
• 238000002965 ELISA Methods 0.000 description 16
• 241000295644 Staphylococcaceae Species 0.000 description 16
• 210000004379 membrane Anatomy 0.000 description 16
• 239000012528 membrane Substances 0.000 description 16
• 101150012518 lamB gene Proteins 0.000 description 14
• 101100398653 Yersinia pestis lamB1 gene Proteins 0.000 description 13
• 238000010790 dilution Methods 0.000 description 13
• 239000012895 dilution Substances 0.000 description 13
• 238000000338 in vitro Methods 0.000 description 13
• 239000013612 plasmid Substances 0.000 description 12
• 239000013598 vector Substances 0.000 description 12
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 11
• 101100390711 Escherichia coli (strain K12) fhuA gene Proteins 0.000 description 11
• 230000000941 anti-staphylcoccal effect Effects 0.000 description 11
• 210000000987 immune system Anatomy 0.000 description 11
• 230000004044 response Effects 0.000 description 11
• 241000588724 Escherichia coli Species 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 10
• 201000010099 disease Diseases 0.000 description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
• 238000012163 sequencing technique Methods 0.000 description 10
• 238000002255 vaccination Methods 0.000 description 10
• 108010007004 cathelin Proteins 0.000 description 9
• 229940079593 drug Drugs 0.000 description 9
• 239000000499 gel Substances 0.000 description 9
• 229930027917 kanamycin Natural products 0.000 description 9
• 229960000318 kanamycin Drugs 0.000 description 9
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 9
• 229930182823 kanamycin A Natural products 0.000 description 9
• 230000014207 opsonization Effects 0.000 description 9
• 238000001262 western blot Methods 0.000 description 9
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
• 230000000295 complement effect Effects 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 230000003053 immunization Effects 0.000 description 8
• 238000002649 immunization Methods 0.000 description 8
• 239000003053 toxin Substances 0.000 description 8
• 231100000765 toxin Toxicity 0.000 description 8
• 108700012359 toxins Proteins 0.000 description 8
• 238000005406 washing Methods 0.000 description 8
• 108090000204 Dipeptidase 1 Proteins 0.000 description 7
• 238000012286 ELISA Assay Methods 0.000 description 7
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 7
• 108010013639 Peptidoglycan Proteins 0.000 description 7
• 206010057249 Phagocytosis Diseases 0.000 description 7
• 101100501302 Staphylococcus aureus emp gene Proteins 0.000 description 7
• 210000000612 antigen-presenting cell Anatomy 0.000 description 7
• 238000013459 approach Methods 0.000 description 7
• 239000000969 carrier Substances 0.000 description 7
• 238000002474 experimental method Methods 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 230000004807 localization Effects 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 230000000405 serological effect Effects 0.000 description 7
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• 102000014914 Carrier Proteins Human genes 0.000 description 6
• 102000008070 Interferon-gamma Human genes 0.000 description 6
• 108010074328 Interferon-gamma Proteins 0.000 description 6
• 102000003939 Membrane transport proteins Human genes 0.000 description 6
• 108090000301 Membrane transport proteins Proteins 0.000 description 6
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 6
• 108010076504 Protein Sorting Signals Proteins 0.000 description 6
• 206010040047 Sepsis Diseases 0.000 description 6
• 239000003242 anti bacterial agent Substances 0.000 description 6
• 229940088710 antibiotic agent Drugs 0.000 description 6
• 102000006635 beta-lactamase Human genes 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 230000007123 defense Effects 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 231100000776 exotoxin Toxicity 0.000 description 6
• 239000002095 exotoxin Substances 0.000 description 6
• 210000005007 innate immune system Anatomy 0.000 description 6
• 229960003130 interferon gamma Drugs 0.000 description 6
• 238000001155 isoelectric focusing Methods 0.000 description 6
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 6
• 230000003472 neutralizing effect Effects 0.000 description 6
• 230000008782 phagocytosis Effects 0.000 description 6
• 238000002702 ribosome display Methods 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• 230000032258 transport Effects 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 5
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 5
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 5
• 208000031729 Bacteremia Diseases 0.000 description 5
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
• 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 5
• 102100038823 RNA-binding protein 45 Human genes 0.000 description 5
• 210000005006 adaptive immune system Anatomy 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 230000000903 blocking effect Effects 0.000 description 5
• 230000032823 cell division Effects 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 230000029087 digestion Effects 0.000 description 5
• 238000010828 elution Methods 0.000 description 5
• 239000000284 extract Substances 0.000 description 5
• 210000000224 granular leucocyte Anatomy 0.000 description 5
• 230000005847 immunogenicity Effects 0.000 description 5
• 230000001939 inductive effect Effects 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 239000000651 prodrug Substances 0.000 description 5
• 229940002612 prodrug Drugs 0.000 description 5
• 210000003491 skin Anatomy 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 239000000758 substrate Substances 0.000 description 5
• 108010078791 Carrier Proteins Proteins 0.000 description 4
• 208000017667 Chronic Disease Diseases 0.000 description 4
• 102000004127 Cytokines Human genes 0.000 description 4
• 108090000695 Cytokines Proteins 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 101000833492 Homo sapiens Jouberin Proteins 0.000 description 4
• 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 4
• 206010061598 Immunodeficiency Diseases 0.000 description 4
• 102100024407 Jouberin Human genes 0.000 description 4
• RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 4
• 102000004316 Oxidoreductases Human genes 0.000 description 4
• 108090000854 Oxidoreductases Proteins 0.000 description 4
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
• 102100033254 Tumor suppressor ARF Human genes 0.000 description 4
• 101710102803 Tumor suppressor ARF Proteins 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 230000002776 aggregation Effects 0.000 description 4
• 238000004220 aggregation Methods 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000000845 anti-microbial effect Effects 0.000 description 4
• 108091008324 binding proteins Proteins 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 101150103637 bkdB gene Proteins 0.000 description 4
• 201000011510 cancer Diseases 0.000 description 4
• 210000000170 cell membrane Anatomy 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 238000009826 distribution Methods 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 238000011156 evaluation Methods 0.000 description 4
• 150000004676 glycans Chemical class 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000015654 memory Effects 0.000 description 4
• 229960003085 meticillin Drugs 0.000 description 4
• 244000005700 microbiome Species 0.000 description 4
• 101150028177 pdhB gene Proteins 0.000 description 4
• 101150086832 pdhC gene Proteins 0.000 description 4
• 229920001282 polysaccharide Polymers 0.000 description 4
• 239000005017 polysaccharide Substances 0.000 description 4
• 230000001681 protective effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 229940031626 subunit vaccine Drugs 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• YQNRVGJCPCNMKT-JLPGSUDCSA-N 2-(4-benzylpiperazin-1-yl)-n-[(2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino]acetamide Chemical compound OC1=C(CC=C)C=CC=C1\C=N/NC(=O)CN1CCN(CC=2C=CC=CC=2)CC1 YQNRVGJCPCNMKT-JLPGSUDCSA-N 0.000 description 3
• 208000030090 Acute Disease Diseases 0.000 description 3
• 101100507429 Bacillus subtilis (strain 168) hxlA gene Proteins 0.000 description 3
• 102100026189 Beta-galactosidase Human genes 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 108010065152 Coagulase Proteins 0.000 description 3
• 208000035473 Communicable disease Diseases 0.000 description 3
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 3
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 108010006464 Hemolysin Proteins Proteins 0.000 description 3
• 101001139126 Homo sapiens Krueppel-like factor 6 Proteins 0.000 description 3
• 101000734579 Homo sapiens Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Proteins 0.000 description 3
• 101001133600 Homo sapiens Pituitary adenylate cyclase-activating polypeptide type I receptor Proteins 0.000 description 3
• 101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 description 3
• 101001104570 Homo sapiens Proteasome assembly chaperone 2 Proteins 0.000 description 3
• 101000625842 Homo sapiens Tubulin-specific chaperone E Proteins 0.000 description 3
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• 102100020679 Krueppel-like factor 6 Human genes 0.000 description 3
• 102000004882 Lipase Human genes 0.000 description 3
• 108090001060 Lipase Proteins 0.000 description 3
• 239000004367 Lipase Substances 0.000 description 3
• 108090001030 Lipoproteins Proteins 0.000 description 3
• 102000004895 Lipoproteins Human genes 0.000 description 3
• 239000006142 Luria-Bertani Agar Substances 0.000 description 3
• 108090000988 Lysostaphin Proteins 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 241000699670 Mus sp. Species 0.000 description 3
• 229960005552 PAC-1 Drugs 0.000 description 3
• 238000010222 PCR analysis Methods 0.000 description 3
• 239000002033 PVDF binder Substances 0.000 description 3
• 101100463787 Pectobacterium carotovorum subsp. carotovorum peh gene Proteins 0.000 description 3
• 102100034792 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Human genes 0.000 description 3
• 229920001213 Polysorbate 20 Polymers 0.000 description 3
• 102100041008 Proteasome assembly chaperone 2 Human genes 0.000 description 3
• 101500027983 Rattus norvegicus Octadecaneuropeptide Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 101000815632 Streptococcus suis (strain 05ZYH33) Rqc2 homolog RqcH Proteins 0.000 description 3
• 101710120037 Toxin CcdB Proteins 0.000 description 3
• 108010031318 Vitronectin Proteins 0.000 description 3
• 102100035140 Vitronectin Human genes 0.000 description 3
• 206010048038 Wound infection Diseases 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 230000003044 adaptive effect Effects 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 238000013019 agitation Methods 0.000 description 3
• 229960000723 ampicillin Drugs 0.000 description 3
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 230000002238 attenuated effect Effects 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 101150049515 bla gene Proteins 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• 125000002091 cationic group Chemical group 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 230000002860 competitive effect Effects 0.000 description 3
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• 238000000502 dialysis Methods 0.000 description 3
• 238000002283 elective surgery Methods 0.000 description 3
• 230000008030 elimination Effects 0.000 description 3
• 238000003379 elimination reaction Methods 0.000 description 3
• 206010014665 endocarditis Diseases 0.000 description 3
• 102000036072 fibronectin binding proteins Human genes 0.000 description 3
• 239000003228 hemolysin Substances 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• 230000006054 immunological memory Effects 0.000 description 3
• 230000001965 increasing effect Effects 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 229910052742 iron Inorganic materials 0.000 description 3
• 235000019421 lipase Nutrition 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 3
• 210000001322 periplasm Anatomy 0.000 description 3
• 206010034674 peritonitis Diseases 0.000 description 3
• 239000012071 phase Substances 0.000 description 3
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 230000003449 preventive effect Effects 0.000 description 3
• 230000001737 promoting effect Effects 0.000 description 3
• 101150108007 prs gene Proteins 0.000 description 3
• 101150086435 prs1 gene Proteins 0.000 description 3
• 101150070305 prsA gene Proteins 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 231100000617 superantigen Toxicity 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
• 108091006112 ATPases Proteins 0.000 description 2
• 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 2
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
• 108700028369 Alleles Proteins 0.000 description 2
• 108700042778 Antimicrobial Peptides Proteins 0.000 description 2
• 102000044503 Antimicrobial Peptides Human genes 0.000 description 2
• 206010053555 Arthritis bacterial Diseases 0.000 description 2
• 101100311413 Bacillus subtilis (strain 168) sufD gene Proteins 0.000 description 2
• 101100213134 Bacillus subtilis (strain 168) ydaP gene Proteins 0.000 description 2
• LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 102100033238 Elongation factor Tu, mitochondrial Human genes 0.000 description 2
• 101100126177 Escherichia coli (strain K12) intR gene Proteins 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
• 101000851240 Homo sapiens Elongation factor Tu, mitochondrial Proteins 0.000 description 2
• 101000802734 Homo sapiens eIF5-mimic protein 2 Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 102000028555 IgG binding proteins Human genes 0.000 description 2
• 108091009325 IgG binding proteins Proteins 0.000 description 2
• 208000004575 Infectious Arthritis Diseases 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
• 201000005505 Measles Diseases 0.000 description 2
• 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 101710116435 Outer membrane protein Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108010000605 Ribosomal Proteins Proteins 0.000 description 2
• 102000002278 Ribosomal Proteins Human genes 0.000 description 2
• 108091003202 SecA Proteins Proteins 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 241000191940 Staphylococcus Species 0.000 description 2
• 241000344863 Staphylococcus aureus subsp. aureus COL Species 0.000 description 2
• 241001147691 Staphylococcus saprophyticus Species 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 241000193985 Streptococcus agalactiae Species 0.000 description 2
• 102000003673 Symporters Human genes 0.000 description 2
• 108090000088 Symporters Proteins 0.000 description 2
• 230000005867 T cell response Effects 0.000 description 2
• 206010043376 Tetanus Diseases 0.000 description 2
• 102000004357 Transferases Human genes 0.000 description 2
• 108090000992 Transferases Proteins 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 206010052428 Wound Diseases 0.000 description 2
• 101150070497 accC gene Proteins 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000004520 agglutination Effects 0.000 description 2
• 238000004873 anchoring Methods 0.000 description 2
• 101150042295 arfA gene Proteins 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 238000004422 calculation algorithm Methods 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 229940030156 cell vaccine Drugs 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 238000004891 communication Methods 0.000 description 2
• 230000009260 cross reactivity Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 206010013023 diphtheria Diseases 0.000 description 2
• 230000006806 disease prevention Effects 0.000 description 2
• 102100035859 eIF5-mimic protein 2 Human genes 0.000 description 2
• 108010064033 elastin-binding proteins Proteins 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 102000033737 extracellular matrix binding proteins Human genes 0.000 description 2
• 108091009712 extracellular matrix binding proteins Proteins 0.000 description 2
• 101150090981 fabG gene Proteins 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 239000010437 gem Substances 0.000 description 2
• 238000001631 haemodialysis Methods 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 230000000322 hemodialysis Effects 0.000 description 2
• 108010025743 hexose phosphate synthetase Proteins 0.000 description 2
• -1 human growth hormone Chemical class 0.000 description 2
• 230000008348 humoral response Effects 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 101150068528 mabA gene Proteins 0.000 description 2
• 229940049920 malate Drugs 0.000 description 2
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
• 239000004005 microsphere Substances 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 210000004877 mucosa Anatomy 0.000 description 2
• 210000004400 mucous membrane Anatomy 0.000 description 2
• 101150087557 omcB gene Proteins 0.000 description 2
• 101150115693 ompA gene Proteins 0.000 description 2
• 230000000399 orthopedic effect Effects 0.000 description 2
• UOJMTSCORVQOHS-UHFFFAOYSA-N pachypodol Natural products COc1cc(ccc1O)C2=C(C)C(=O)c3c(O)cc(C)cc3O2 UOJMTSCORVQOHS-UHFFFAOYSA-N 0.000 description 2
• AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 235000019271 petrolatum Nutrition 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 229920001308 poly(aminoacid) Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000009465 prokaryotic expression Effects 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 230000005180 public health Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 230000003252 repetitive effect Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
• 101150085857 rpo2 gene Proteins 0.000 description 2
• 101150090202 rpoB gene Proteins 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 201000001223 septic arthritis Diseases 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052938 sodium sulfate Inorganic materials 0.000 description 2
• 235000011152 sodium sulphate Nutrition 0.000 description 2
• 239000011550 stock solution Substances 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 108010087967 type I signal peptidase Proteins 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
• MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
• 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 1
• 238000010600 3H thymidine incorporation assay Methods 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 101710111176 5'-methylthioadenosine nucleosidase Proteins 0.000 description 1
• 101710185027 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase Proteins 0.000 description 1
• 101710186604 65 kDa membrane protein Proteins 0.000 description 1
• VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
• 101710162806 Accumulation-associated protein Proteins 0.000 description 1
• 101000818108 Acholeplasma phage L2 Uncharacterized 81.3 kDa protein Proteins 0.000 description 1
• 101100016043 Acidianus filamentous virus 1 (isolate United States/Yellowstone) ORF300 gene Proteins 0.000 description 1
• 101100265191 Acidianus filamentous virus 2 (isolate Italy/Pozzuoli) ORF208 gene Proteins 0.000 description 1
• 108700016155 Acyl transferases Proteins 0.000 description 1
• 102000057234 Acyl transferases Human genes 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 1
• 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 1
• 102000003669 Antiporters Human genes 0.000 description 1
• 108090000084 Antiporters Proteins 0.000 description 1
• 241000244185 Ascaris lumbricoides Species 0.000 description 1
• 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 101000952999 Bacillus subtilis (strain 168) Putative esterase ComA2 Proteins 0.000 description 1
• 101100406318 Bacillus subtilis (strain 168) bfmBB gene Proteins 0.000 description 1
• 101100076641 Bacillus subtilis (strain 168) metE gene Proteins 0.000 description 1
• 101100360891 Bacillus subtilis (strain 168) rnjB gene Proteins 0.000 description 1
• 101100432201 Bacillus subtilis (strain 168) yhjN gene Proteins 0.000 description 1
• 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 1
• 101000742291 Bifidobacterium adolescentis (strain ATCC 15703 / DSM 20083 / NCTC 11814 / E194a) Reducing end xylose-releasing exo-oligoxylanase Proteins 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 108090000056 Complement factor B Proteins 0.000 description 1
• 102000003712 Complement factor B Human genes 0.000 description 1
• 108010060123 Conjugate Vaccines Proteins 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 206010011409 Cross infection Diseases 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
• NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
• 238000007400 DNA extraction Methods 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 102000000541 Defensins Human genes 0.000 description 1
• 108010002069 Defensins Proteins 0.000 description 1
• 206010064687 Device related infection Diseases 0.000 description 1
• 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 1
• 108010014258 Elastin Proteins 0.000 description 1
• 102000016942 Elastin Human genes 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 1
• 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 1
• 101000995033 Escherichia coli (strain K12) Cysteine desulfurase IscS Proteins 0.000 description 1
• 101100218573 Escherichia coli (strain K12) bcsB gene Proteins 0.000 description 1
• 101100300893 Escherichia coli (strain K12) ratB gene Proteins 0.000 description 1
• 101100213809 Escherichia coli (strain K12) ymfA gene Proteins 0.000 description 1
• 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
• 101100518975 Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) pasI gene Proteins 0.000 description 1
• 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 1
• 241000495778 Escherichia faecalis Species 0.000 description 1
• VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 101710128530 Fibrinogen-binding protein Proteins 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 102000016359 Fibronectins Human genes 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 1
• 206010016952 Food poisoning Diseases 0.000 description 1
• 208000019331 Foodborne disease Diseases 0.000 description 1
• VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• 101000965172 Glycine max Isocitrate lyase 1 Proteins 0.000 description 1
• 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 101000912350 Haemophilus phage HP1 (strain HP1c1) DNA N-6-adenine-methyltransferase Proteins 0.000 description 1
• 101710154606 Hemagglutinin Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 108010072039 Histidine kinase Proteins 0.000 description 1
• 101000864089 Homo sapiens HLA class II histocompatibility antigen, DP alpha 1 chain Proteins 0.000 description 1
• 101000930802 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 1 chain Proteins 0.000 description 1
• 101000968032 Homo sapiens HLA class II histocompatibility antigen, DR beta 3 chain Proteins 0.000 description 1
• 101001104566 Homo sapiens Proteasome assembly chaperone 3 Proteins 0.000 description 1
• 101000717377 Homo sapiens Ribokinase Proteins 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• 241000274177 Juniperus sabina Species 0.000 description 1
• 101000790844 Klebsiella pneumoniae Uncharacterized 24.8 kDa protein in cps region Proteins 0.000 description 1
• 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• 108010059881 Lactase Proteins 0.000 description 1
• 108010085895 Laminin Proteins 0.000 description 1
• 102000007547 Laminin Human genes 0.000 description 1
• 241000270322 Lepidosauria Species 0.000 description 1
• 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 1
• 101710177649 Low affinity immunoglobulin gamma Fc region receptor III Proteins 0.000 description 1
• 101710099301 Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
• 108090000856 Lyases Proteins 0.000 description 1
• 102000004317 Lyases Human genes 0.000 description 1
• 102000008826 LysM domains Human genes 0.000 description 1
• 108050000721 LysM domains Proteins 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 1
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N Methyl ethyl ketone Natural products CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
• 108050008554 Multidrug resistance protein MdtK Proteins 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 101100426292 Myxococcus xanthus (strain DK1622) trmFO gene Proteins 0.000 description 1
• 101150042817 NFS1 gene Proteins 0.000 description 1
• 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 1
• 108090000836 Nitrate Transporters Proteins 0.000 description 1
• 208000031662 Noncommunicable disease Diseases 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 101000783504 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 15.4 kDa protein Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 206010031252 Osteomyelitis Diseases 0.000 description 1
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
• 238000009004 PCR Kit Methods 0.000 description 1
• 108091081548 Palindromic sequence Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108090000279 Peptidyltransferases Proteins 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 102100029251 Phagocytosis-stimulating peptide Human genes 0.000 description 1
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
• 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 description 1
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 101100274323 Pinus contorta chlN gene Proteins 0.000 description 1
• 241001442539 Plasmodium sp. Species 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
• 229920002873 Polyethylenimine Polymers 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 101710092974 Probable quinol oxidase subunit 1 Proteins 0.000 description 1
• 108010059712 Pronase Proteins 0.000 description 1
• 102100041010 Proteasome assembly chaperone 3 Human genes 0.000 description 1
• 101710176177 Protein A56 Proteins 0.000 description 1
• 101710132637 Protein C2 Proteins 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 101710132697 Protein L2 Proteins 0.000 description 1
• 101100438336 Pseudomonas phage KPP25 ORF017 gene Proteins 0.000 description 1
• 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 1
• 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
• 101710088619 Quinol oxidase subunit 1 Proteins 0.000 description 1
• 238000010802 RNA extraction kit Methods 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
• 102100020783 Ribokinase Human genes 0.000 description 1
• 108010046983 Ribonuclease T1 Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 102000004208 Ribosomal protein L2 Human genes 0.000 description 1
• 108090000775 Ribosomal protein L2 Proteins 0.000 description 1
• 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000701062 Saimiriine gammaherpesvirus 2 Species 0.000 description 1
• 229940125377 Selective β-Amyloid-Lowering Agent Drugs 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 206010058028 Shunt infection Diseases 0.000 description 1
• 206010062255 Soft tissue infection Diseases 0.000 description 1
• 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 1
• 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 208000002847 Surgical Wound Diseases 0.000 description 1
• 208000031650 Surgical Wound Infection Diseases 0.000 description 1
• 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 1
• 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 1
• 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 241000244159 Taenia saginata Species 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 206010044248 Toxic shock syndrome Diseases 0.000 description 1
• 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
• 101710195626 Transcriptional activator protein Proteins 0.000 description 1
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108010084754 Tuftsin Proteins 0.000 description 1
• MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
• 101710100170 Unknown protein Proteins 0.000 description 1
• 108010059993 Vancomycin Proteins 0.000 description 1
• 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 1
• 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 101150057540 aar gene Proteins 0.000 description 1
• 206010000269 abscess Diseases 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000008649 adaptation response Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000005273 aeration Methods 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 230000004523 agglutinating effect Effects 0.000 description 1
• 229960003767 alanine Drugs 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000008346 aqueous phase Substances 0.000 description 1
• 201000009361 ascariasis Diseases 0.000 description 1
• OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
• 229940065181 bacillus anthracis Drugs 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 229960001212 bacterial vaccine Drugs 0.000 description 1
• 101150099720 basR gene Proteins 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 239000007621 bhi medium Substances 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 101150098189 brnQ gene Proteins 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 102000014509 cathelicidin Human genes 0.000 description 1
• 108060001132 cathelicidin Proteins 0.000 description 1
• POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000002032 cellular defenses Effects 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 239000002975 chemoattractant Substances 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 229940001442 combination vaccine Drugs 0.000 description 1
• 229940031670 conjugate vaccine Drugs 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 238000006356 dehydrogenation reaction Methods 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• VLYUGYAKYZETRF-UHFFFAOYSA-N dihydrolipoamide Chemical compound NC(=O)CCCCC(S)CCS VLYUGYAKYZETRF-UHFFFAOYSA-N 0.000 description 1
• WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 108010024615 duroquinol oxidase Proteins 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 229920002549 elastin Polymers 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 239000011536 extraction buffer Substances 0.000 description 1
• 101150077341 fhuA gene Proteins 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 102000025748 fibrinogen binding proteins Human genes 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
• 235000008191 folinic acid Nutrition 0.000 description 1
• 239000011672 folinic acid Substances 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000002682 general surgery Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 239000011544 gradient gel Substances 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 150000002402 hexoses Chemical class 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 239000012642 immune effector Substances 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000002998 immunogenetic effect Effects 0.000 description 1
• 230000009851 immunogenic response Effects 0.000 description 1
• 230000007233 immunological mechanism Effects 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 229960001438 immunostimulant agent Drugs 0.000 description 1
• 239000003022 immunostimulating agent Substances 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 235000000396 iron Nutrition 0.000 description 1
• 101150039690 isaA gene Proteins 0.000 description 1
• 229940116108 lactase Drugs 0.000 description 1
• 229960001691 leucovorin Drugs 0.000 description 1
• 125000005647 linker group Chemical group 0.000 description 1
• FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 238000000464 low-speed centrifugation Methods 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000007257 malfunction Effects 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 208000004396 mastitis Diseases 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000006386 memory function Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 101150117293 metC gene Proteins 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000012009 microbiological test Methods 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000033607 mismatch repair Effects 0.000 description 1
• 101150034648 mnmG gene Proteins 0.000 description 1
• MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
• 235000013919 monopotassium glutamate Nutrition 0.000 description 1
• 230000016379 mucosal immune response Effects 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 229960003128 mupirocin Drugs 0.000 description 1
• 229930187697 mupirocin Natural products 0.000 description 1
• DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
• 210000004897 n-terminal region Anatomy 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 125000003729 nucleotide group Chemical group 0.000 description 1
• 244000039328 opportunistic pathogen Species 0.000 description 1
• 230000003571 opsonizing effect Effects 0.000 description 1
• 229940127241 oral polio vaccine Drugs 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 231100000255 pathogenic effect Toxicity 0.000 description 1
• 238000003909 pattern recognition Methods 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 210000002640 perineum Anatomy 0.000 description 1
• 201000001245 periodontitis Diseases 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 101150069659 pmrA gene Proteins 0.000 description 1
• 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 229940023143 protein vaccine Drugs 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
• 235000008001 rakum palm Nutrition 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
• 229960001225 rifampicin Drugs 0.000 description 1
• 229920002477 rna polymer Polymers 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 238000013515 script Methods 0.000 description 1
• 101150064504 sdrC gene Proteins 0.000 description 1
• 101150073644 sdrE gene Proteins 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 208000013223 septicemia Diseases 0.000 description 1
• 208000026425 severe pneumonia Diseases 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 230000003393 splenic effect Effects 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 229940037645 staphylococcus epidermidis Drugs 0.000 description 1
• 239000000021 stimulant Substances 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 238000004885 tandem mass spectrometry Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 229940021747 therapeutic vaccine Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 229960001005 tuberculin Drugs 0.000 description 1
• 229940035670 tuftsin Drugs 0.000 description 1
• IESDGNYHXIOKRW-LEOABGAYSA-N tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 208000019206 urinary tract infection Diseases 0.000 description 1
• 229960003165 vancomycin Drugs 0.000 description 1
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 229960004854 viral vaccine Drugs 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1